PC12 cells (1×105/well) were seeded in 6-well plates overnight, and the cells were treated as follows: PC12 cells were transfected with miR-335 mimic, miR-335 inhibitor, miR-335 NC, or siRNA-FTH1, respectively, and then stimulated with 6-OHDA (50 µM) for 24 h; PC12 cells were treated with Erastin (cat. no. HY-15763, MedChem Express), Fer-1 (cat. no. HY-100579, MedChem Express), DFO (cat. no. HY-B0988, MedChem Express) or Z-VAD-FMK (cat. no. HY-16658B MedChem Express) for 24 h, respectively, and then stimulated with 6-OHDA (50 µM) for 24 h. The cells were incubated with 10 µM C11-BODIPY (581/591; cat. no. D3861, Thermo Fisher Scientific, Inc.) for 30 min at 37°C, then washed with PBS 3 times. Cells were harvested with trypsin (cat. no. 15050-065, Gibco; Thermo Fisher Scientific, Inc.), suspended in fresh medium, and analyzed using a CytoFLEX flow cytometer (Beckman Coulter, Inc.). Fluorescence was measured by acquiring green (484/510 nm). The butadienyl portion of C11-BODIPY581/591 was oxidized, resulting in the 510 nm fluorescence emission peak. The data were analyzed using FlowJo v10 software.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.